• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.04% Nasdaq Down 1.11%

    Delcath Systems, Inc. (DCTH)

    -NasdaqCM
    0.85 Down 0.03(3.66%) May 26, 3:49PM EDT
    Add to Portfolio
    Prev Close:0.88
    Open:0.89
    Bid:0.71 x 2500
    Ask:3.67 x 2500
    1y Target Est:1.30
    Beta:1.71
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:0.85 - 0.95
    52wk Range:0.80 - 3.00
    Volume:108,303
    Avg Vol (3m):91,133
    Market Cap:10.35M
    P/E (ttm):N/A
    EPS (ttm):-1.58
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for DCTH

    Comparison

    Symbol% ChgMkt Cap
    DCTHDown 3.66%10.35M
    LLYUp 0.01%78.69B
    ONXX 0.00%N/A
    PFEDown 0.50%210.04B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):8.93
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (Jun-14) :N/A
    Mean Recommendation*:4.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Deli... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback